NAD+ and Inflammaging: Why Your Body's Chronic Inflammation Gets Worse After 40

You eat well. You exercise. You get (mostly) enough sleep. So why do you wake up feeling like your body is running on half a charge? Why does recovery take longer, focus feel harder, and energy feel like something you have to budget instead of something that just flows?

The answer may lie not in your habits but in your cells. Specifically, in a molecule called NAD+ (nicotinamide adenine dinucleotide) and a process researchers have given a very apt name: inflammaging.

It sounds like a portmanteau someone coined at a longevity conference (because it was), but it describes something real and measurable. Inflammaging is the low-grade, chronic, systemic inflammation that accumulates as we age, and it's now considered one of the primary drivers of how we feel and function after 40. And NAD+, it turns out, sits right at the intersection of this process.

---

What Is Inflammaging? (And Why It Matters More Than Acute Inflammation)

Most of us think of inflammation as the swelling and redness around a sprained ankle. That's acute inflammation: fast, purposeful, and self-limiting. It shows up, does its job, and leaves.

Inflammaging is different. It's a smoldering, persistent state of low-level immune activation that never quite turns off. There's no dramatic swelling, no obvious injury. But at the cellular level, inflammatory signaling molecules called cytokines (particularly IL-6, TNF-alpha, and IL-1beta) are elevated and chronically active.

What does this feel like in practice? Persistent fatigue that sleep doesn't fix. Brain fog that clouds your thinking by midday. Slower post-exercise recovery. Joint stiffness. A general sense of running 10 percent below your optimal capacity. Sound familiar?

Importantly, inflammaging doesn't just make you feel older. Research published in Frontiers in Aging connects it to metabolic dysfunction, cardiovascular disease, neurodegeneration, and impaired immune function [1]. It's not a side effect of aging. It's increasingly considered a cause of it.

---

The NAD+ Decline Problem: Your Cells Are Running Out of Fuel

Here's where it gets interesting. NAD+ is a coenzyme found in every living cell. Its primary job is to facilitate energy transfer in your mitochondria, the organelles that power virtually every cellular process. But NAD+ does far more than generate ATP.

It's also the essential fuel for sirtuins, a family of proteins sometimes called "longevity regulators." Sirtuins govern DNA repair, cellular stress responses, metabolic regulation, and critically, inflammation. When sirtuins are active and well-fed with NAD+, they help suppress inflammatory pathways. When they aren't, those pathways run unchecked.

The problem is that NAD+ levels drop significantly with age. Research consistently shows that circulating NAD+ in humans falls by roughly 50 percent between the ages of 40 and 60 [2]. This isn't a rounding error. It's a fundamental shift in your cellular chemistry, and it has downstream consequences for everything from mitochondrial health to how your immune system calibrates itself.

"NAD+ depletion simultaneously drives mitochondrial dysfunction, genomic instability, epigenetic alterations, cellular senescence, and chronic inflammation, making it a central node in the aging process." — Nature Reviews Molecular Cell Biology

Put simply: when NAD+ drops, the cellular infrastructure that keeps inflammation regulated starts to erode. And because inflammation accelerates NAD+ depletion (it's a feedback loop), the situation compounds over time.

---

The Research: What Human Trials Actually Show

The NAD+ and aging field has matured considerably over the last several years, moving from exciting mouse studies to well-designed human clinical trials.

A landmark multicentre, randomized, double-blind, placebo-controlled trial published in Frontiers in Aging enrolled 66 healthy adults between ages 40 and 65. Participants who supplemented with NMN (a direct NAD+ precursor) for 60 days showed a 38 percent increase in serum NAD+ levels compared to baseline, against just 14.3 percent in the placebo group. They also demonstrated significant improvements in quality-of-life scores and metabolic markers [2].

A separate randomized controlled trial published in GeroScience in 2024 evaluated NMN supplementation in older adults over 12 weeks. Beyond confirming elevated blood NAD+ levels, researchers found that the NMN group maintained walking speed (a key functional aging marker) and reported meaningfully improved sleep quality compared to placebo. The authors concluded NMN supplementation may support both physical function and recovery-related endpoints [3].

The inflammation connection was further illuminated by a randomized clinical trial published in The Journals of Gerontology by Kumar et al. That study examined GlyNAC (a glutathione precursor combination), but measured inflammaging markers directly. The researchers found that correcting cellular antioxidant and mitochondrial deficits in older adults significantly improved multiple aging hallmarks, including markers of systemic inflammation, oxidative stress, and mitochondrial dysfunction simultaneously [4].

Meanwhile, a comprehensive review in the American Journal of Physiology: Endocrinology and Metabolism evaluated the full landscape of NAD+ clinical evidence across disease contexts and concluded that NAD+ replenishment is safe, well-tolerated, and consistently raises biomarker levels in humans across multiple delivery formats and populations [5].

---

Sirtuins: The Missing Link Between NAD+ and Inflammation Control

You can't talk about NAD+ and inflammaging without talking about sirtuins. There are seven sirtuin proteins (SIRT1-SIRT7) and they require NAD+ to function. Think of them as a fleet of maintenance workers who can only operate while the lights are on. NAD+ is the electricity.

When sirtuins are active, they deacetylate proteins that regulate NF-kB, the master transcription factor for inflammatory gene expression. In plain language: well-fed sirtuins help keep the inflammatory "volume dial" turned down.

SIRT1 and SIRT3 are particularly relevant here. SIRT1 modulates immune cell behavior and has been shown to inhibit NF-kB-driven inflammatory cascades. SIRT3 lives in mitochondria, where it protects against oxidative stress and the reactive oxygen species that trigger cellular damage signals. Both are compromised when NAD+ is low.

This is why aging doesn't just make you more susceptible to one thing. It dysregulates a whole constellation of systems that were designed to work in concert. NAD+ is the common thread running through many of them.

---

Why Injectable NAD+ May Work Differently Than Oral Supplements

If you've tried oral NAD+ precursors (NMN or NR capsules) and felt underwhelmed, you're not alone. The challenge with oral supplementation is bioavailability: the digestive process partially degrades these compounds before they can be absorbed and converted.

Injectable NAD+ bypasses the gastrointestinal tract entirely. It enters the bloodstream directly, making the full dose bioavailable for cellular uptake. Patients who have tried both routes frequently report a more pronounced and faster-onset response with injectable forms.

There's a reason many longevity clinics and physician-supervised wellness programs have moved toward injectable delivery. For people in their 40s and 50s who are experiencing the real-world effects of NAD+ decline, including persistent fatigue, slower recovery, and the diffuse cognitive edge-blunting that often gets blamed on "just getting older," the injectable route offers a more direct path to restoring cellular levels.

At RenuviaRX, physician-supervised NAD+ injections are compounded through Strive Pharmacy and prescribed following a digital health questionnaire, making the process accessible without requiring an in-clinic appointment.

---

What This Means for How You Feel Day-to-Day

Let's connect the science back to lived experience.

The inflammaging picture explains a lot about the symptoms that tend to creep up in the 40s and 50s with no single identifiable cause. The cellular energy slump that makes afternoons feel like wading through fog. The sleep that doesn't fully restore. The slight but persistent sense of systemic heaviness that's hard to describe to a doctor but unmistakable to the person experiencing it.

NAD+ depletion doesn't announce itself with a single dramatic symptom. It's cumulative and quiet. But because it sits upstream of so many regulatory pathways, restoring it has the potential to support multiple systems at once: mitochondrial energy production, DNA repair, sirtuin-mediated inflammation control, and metabolic function.

Participants in clinical trials report improvements in physical function, sleep quality, and quality-of-life scores [3]. These are not minor markers. They're the daily experience of feeling well.

---

The Takeaway: Cellular Health Is the Foundation of How You Age

Inflammaging is not inevitable. It's a measurable, addressable process that begins with cellular-level changes that science is increasingly able to characterize and target.

NAD+ sits at the center of that picture: as a direct energy currency for your mitochondria, as the substrate your sirtuin proteins need to keep inflammatory pathways regulated, and as a marker whose decline tracks closely with many of the functional changes people associate with "getting older."

The good news is that NAD+ levels are not fixed. Human clinical trials show they can be meaningfully raised, and that raising them corresponds to measurable improvements in energy, physical function, sleep, and metabolic health.

The question isn't whether your NAD+ levels have declined. After 40, they almost certainly have. The question is what you want to do about it.

---

Ready to explore how physician-supervised NAD+ therapy might support your energy, focus, and long-term wellness? Start with a free physician assessment at RenuviaRX.

---

References

1. Franceschi C et al. "Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans." Frontiers in Aging, vol. 3, 2022. DOI:10.3389/fragi.2022.852569

2. Irie J et al. "A Multicentre, Randomised, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever (NMN Supplement), an Orally Administered Supplementation in Middle Aged and Older Adults." Frontiers in Aging, vol. 3, 2022. DOI:10.3389/fragi.2022.851698

3. Morifuji M et al. "Ingestion of beta-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study." GeroScience, vol. 46, no. 5, 2024, pp. 4671-4688. DOI:10.1007/s11357-024-01204-1

4. Kumar P, Liu C, Hsu JW, Chacko S, Minard C, Jahoor F, Sekhar RV. "Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial." The Journals of Gerontology: Series A, vol. 78, no. 1, 2023, pp. 75-89. DOI:10.1093/gerona/glac135

5. Braidy N, Liu Y. "NAD+ therapy in age-related degenerative disorders: a benefit/risk analysis." American Journal of Physiology: Endocrinology and Metabolism, 2023. DOI:10.1152/ajpendo.00242.2023

---

These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.